PTC Therapeutics Earnings
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$0.15
PTC Therapeutics earnings summary
PTC Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.15. In its most recent report on Jul 30, 2026 (Q2 2026), PTCT posted EPS of $0.92. Revenue for the quarter was $360.5 million.
Across the last 16 reports, PTCT shares moved an average of 6.5% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
PTCT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $0.92 | — | +7.8% |
| May 7, 2026 | — | $-0.03 | — | -3.0% |
| Feb 19, 2026 | — | $-1.63 | — | -3.5% |
| Nov 4, 2025 | — | $0.20 | — | +4.9% |
| Aug 7, 2025 | — | $-0.83 | — | +7.6% |
| May 6, 2025 | — | $10.04 | — | +4.0% |
| Feb 27, 2025 | — | $-0.85 | — | -4.8% |
| Nov 7, 2024 | — | $-1.39 | — | -11.4% |
| Aug 8, 2024 | — | $-1.29 | — | +6.8% |
| Apr 25, 2024 | — | $-1.20 | — | +15.5% |
| Feb 29, 2024 | — | $-2.07 | — | -2.5% |
| Oct 26, 2023 | — | $-1.76 | — | +5.5% |
| Aug 3, 2023 | — | $-2.66 | — | +7.7% |
| Apr 27, 2023 | — | $-1.88 | — | +1.2% |
| Feb 21, 2023 | — | $-2.35 | — | +6.6% |
| Oct 27, 2022 | — | $-1.53 | — | -10.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.